Clinical Spectrum of Reversible Cerebral Vasoconstriction Syndrome With and Without Angiographic Vasoconstriction: A Retrospective Study of 84 Hospitalized Patients
Brain and Behavior · 2026
DOI: 10.1002/brb3.71775 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2026. Verfasst von Katsuya Takeuchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Headache Center, Tominaga Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Vasoconstriction, Vasospasm, Intracranial, Headache Disorders, Primary. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To determine whether patients with reversible cerebral vasoconstriction syndrome (RCVS) without demonstrable vasoconstriction differ clinically from those with angiographically confirmed vasoconstriction.
Methods
We retrospectively studied consecutive patients with RCVS hospitalized at a tertiary headache center in Japan between February 2011 and March 2026. Patients were classified according to the presence or absence of angiographically demonstrable vasoconstriction on magnetic resonance angiography. Demographic characteristics, clinical features, surrogate markers of disease severity, treatment patterns, triggering factors, neuroimaging abnormalities, and outcomes were compared between groups.
Results
Eighty‐four patients were included: 61 with demonstrable vasoconstriction and 23 without. The two groups did not differ significantly in age (median, 51 vs. 53 years; p = 0.213), female predominance (80% vs. 78%; p = 1.000), or migraine history (59% vs. 57%; p = 1.000). Clinical features were similar, including the number of thunderclap headache episodes (median, 4 vs. 4; p = 0.577) and the interval from the first to the last thunderclap headache (median, 6 vs. 6 days; p = 0.460). Time to hospitalization, length of hospital stay, calcium channel blocker use (98% vs. 100%; p = 1.000), neuroimaging abnormalities (8% vs. 9%; p = 1.000), and persistent neurological sequelae (2% vs. 0%; p = 1.000) were also comparable.
Conclusion
Patients without demonstrable vasoconstriction exhibited clinical characteristics, severity indicators, management, and outcomes similar to those with confirmed vasoconstriction. These findings suggest that the two groups may share a common clinical spectrum; however, confirmation in larger prospective studies is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology and Headache Center, Tominaga Hospital, Osaka, Japan.
ORCID-Profile: Shoji Kikui, Daisuke Danno, Takao Takeshima
Zitieren
APA
Takeuchi, K., Kikui, S., Matsumoto, Y., Murakata, K., Sugiyama, H., Ota, K., Danno, D., Kashiwaya, Y., & Takeshima, T. (2026). Clinical Spectrum of Reversible Cerebral Vasoconstriction Syndrome With and Without Angiographic Vasoconstriction: A Retrospective Study of 84 Hospitalized Patients. Brain and Behavior. https://doi.org/10.1002/brb3.71775
Vancouver
Takeuchi K, Kikui S, Matsumoto Y, Murakata K, Sugiyama H, Ota K, et al. Clinical Spectrum of Reversible Cerebral Vasoconstriction Syndrome With and Without Angiographic Vasoconstriction: A Retrospective Study of 84 Hospitalized Patients. Brain and Behavior. 2026. doi:10.1002/brb3.71775
BibTeX
@article{Takeuchi2026,
author = {Takeuchi, Katsuya and Kikui, Shoji and Matsumoto, Yoshiki and Murakata, Kenji and Sugiyama, Hanako and Ota, Kuniko and Danno, Daisuke and Kashiwaya, Yoshihiro and Takeshima, Takao},
title = {Clinical Spectrum of Reversible Cerebral Vasoconstriction Syndrome With and Without Angiographic Vasoconstriction: A Retrospective Study of 84 Hospitalized Patients},
journal = {Brain and Behavior},
year = {2026},
doi = {10.1002/brb3.71775}
}
EUVIMED